Ca 2+ influx through the CRAC channel in mammalian T cells and mast cells is essential for transcriptional responses and other effector responses to physiological stimuli [1] [2] [3] [4] . Gating of the CRAC channel is a classical instance of store-operated Ca 2+ entry, where an initial release of Ca 2+ from internal cellular stores, by depleting the stores, triggers sustained Ca 2+ signaling due to opening of plasma membrane Ca 2+ channels [5] [6] [7] . RNA interference (RNAi) screens and determination of the genetic basis of a human severe combined immunodeficiency (SCID) syndrome have identified two proteins required for CRAC channel function: STIM1, a protein anchored in the endoplasmic reticulum (ER) that senses depletion of ER Ca 2+ stores [8] [9] [10] , and ORAI1, a pore subunit of a plasma-membrane Ca 2+ channel that is gated directly or indirectly by .
a r t i c l e s Ca 2+ influx through the CRAC channel in mammalian T cells and mast cells is essential for transcriptional responses and other effector responses to physiological stimuli [1] [2] [3] [4] . Gating of the CRAC channel is a classical instance of store-operated Ca 2+ entry, where an initial release of Ca 2+ from internal cellular stores, by depleting the stores, triggers sustained Ca 2+ signaling due to opening of plasma membrane Ca 2+ channels [5] [6] [7] . RNA interference (RNAi) screens and determination of the genetic basis of a human severe combined immunodeficiency (SCID) syndrome have identified two proteins required for CRAC channel function: STIM1, a protein anchored in the endoplasmic reticulum (ER) that senses depletion of ER Ca 2+ stores [8] [9] [10] , and ORAI1, a pore subunit of a plasma-membrane Ca 2+ channel that is gated directly or indirectly by STIM1 (refs. 11-16) .
The early steps of STIM1-ORAI1 signaling have been worked out in studies using engineered fluorescent STIM proteins. STIM1 senses a reduction in the ER luminal Ca 2+ concentration, when Ca 2+ dissociates from its luminal EF hand 1, a canonical helix-loop-helix Ca 2+ -binding motif 9, 10 . Dissociation of Ca 2+ leads to oligomerization of STIM1, followed by a local redistribution within the ER by which STIM1 becomes enriched at sites of ER-plasma membrane apposition, termed "puncta" 9, 10, [17] [18] [19] [20] [21] [22] . Subsequently, STIM1 recruits ORAI1 to ER-plasma membrane contacts, where Ca 2+ enters the cell through the opened ORAI1 channels [23] [24] [25] [26] [27] . Structural and biochemical studies with recombinant ER-luminal portions of STIM1 and STIM2 have illuminated the molecular mechanism by which STIM proteins sense Ca 2+ changes in the ER lumen 28, 29 .
Despite these insights, it remains unclear whether STIM1 directly gates ORAI1 channels. Overexpressed ORAI1 seems to be part of a larger channel complex 30 , and RNAi screens have identified other proteins that contribute measurably to store-operated Ca 2+ entry 12, 13 (S. Sharma, P.G.H. and A.R., unpublished data), leaving open the possibility that proteins in addition to STIM and ORAI have a direct role in channel opening. The observation that overexpression of STIM with ORAI is sufficient for large store-operated Ca 2+ currents 12, 18, 31, 32 has been taken as an indication that STIM by itself can gate ORAI. However, the cells used for expression of STIM and ORAI normally possess a store-operated Ca 2+ entry pathway and may supply other proteins necessary to gate the overexpressed ORAI channels.
To dissect the essential steps in STIM1-ORAI1 signaling, we have expressed ORAI1 in the yeast Saccharomyces cerevisiae and isolated membrane vesicles containing functional ORAI1 channels. The yeast cells do not use the classical store-operated Ca 2+ entry pathway that has been defined in mammalian cells-S. cerevisiae has no appreciable reservoir of Ca 2+ in the ER 33 , does not possess orthologs of the ER Ca 2+ -ATPase (ATP2A1-ATP2A3) or IP3 receptor (ITPR1-ITPR3) 34, 35 and has no STIM or ORAI homologs-and therefore they are not likely to contribute proteins dedicated to this pathway. Here we report that recombinant STIM1 cytoplasmic fragments gate the ORAI1 channel in vitro.
RESULTS

Expression of recombinant ORAI1 and STIM1
We set out to express properly assembled recombinant ORAI1 channels in the yeast S. cerevisiae. S. cerevisiae strains carrying the temperature-sensitive sec6-4 mutation have a defect in fusion of vesicles trafficking from the Golgi compartment to the plasma membrane at the restrictive temperature, 37 °C, and newly synthesized plasmamembrane proteins accumulate in vesicles in the cell cytoplasm 36, 37 nature structural & molecular biology VOLUME 17 NUMBER 1 jaNUaRy 2010 1 1 3 (a) Above, the part of ORAI1 expressed as a membrane protein in P. pastoris is highlighted in red. Below, P. pastoris membranes containing Flag-ORAI1 65-301 E106Q or control membranes, with or without His 6 -STIM1 protein, were loaded at the bottom of a discontinuous sucrose density gradient and subjected to centrifugation. Flag-ORAI1 and His 6 -STIM1 in individual gradient fractions were detected by western blotting (WB). The fraction of unbound STIM1 remaining at the bottom of the gradient is probably due to the presence of a moderate excess of STIM1 over ORAI1 in the assay. (b) Above, the C-terminal cytoplasmic tail of ORAI1 expressed as a GST fusion protein is highlighted in red. Below, the indicated STIM1 fragments were incubated with immobilized GST-ORAI1 259-301 or with GST. Bound proteins were analyzed by SDS-PAGE and staining with Coomassie Brilliant Blue R-250. Samples on the input gel correspond to 20% of protein in the binding assay. (c) Above, the segment ORAI1 65-87 is highlighted in red. Below, STIM1 fragments were incubated with immobilized GST-ORAI1 65-87 or with GST and analyzed as in Figure 2b . Samples on the input gel correspond to 5% of protein in the binding assay.
( Fig. 1a, above) . The isolated vesicles have been used in flux assays to investigate transport mediated by several plasma-membrane proteins [38] [39] [40] [41] , and they seemed particularly suited to our planned experiments because recombinant ORAI1 would be oriented with its cytoplasmic face accessible for interaction with recombinant STIM1 (Fig. 1a, (Fig. 1b) . To investigate the interaction by which STIM1 gates ORAI1 channels, we have focused on the cytoplasmic region of STIM1 (STIM1 CT ), which is sufficient in cells to trigger activation of ORAI1 (refs. 26,42-45) . Sequence alignments of human STIM1 with its vertebrate orthologs show that the region of pronounced conservation ends around residue 531 of human STIM1; additional alignments with insect Stim proteins and with STIM2 show a shorter region of conservation, ending around residue 498 ( Fig. 1c and Supplementary Fig. 1 ). On the premise that interaction with either ORAI itself or other proteins of the ORAI channel complex is a basic function of STIM proteins that will be reflected in sequence conservation, we expressed and purified STIM1 C-terminal proteins truncated at residue 498, at residue 531 and at other sites suggested by sequence conservation. The anchoring of STIM1 in the ER and the measured ER-plasma membrane distance, 17 ± 10 nm (ref. 19) , render it unlikely that the initial part of the STIM1 coiled coil interacts directly with ORAI1, but we have retained the entire coiled coil in our constructs because of its possible role in proper STIM1 multimer assembly. The STIM1 proteins used in this study support store-operated Ca 2+ influx when expressed in mammalian cells (Supplementary Data and Supplementary Figs. 2 and 3) .
Analysis of recombinant STIM1 CT by size exclusion chromatography coupled with multiangle laser light scattering (SEC-MALLS) showed that the freshly prepared protein is dimeric under our conditions in vitro (Fig. 1d) . STIM1 233-498 also formed dimers; STIM1 233-463 was a heterogeneous mixture of trimers and smaller material, tetramers and large aggregates (Fig. 1e) . STIM1 CT and its fragments eluted earlier than expected for compact globular proteins of comparable mass, consistent with an elongated shape, and in particular consistent with the predicted STIM1 coiled coil. CD spectroscopy of STIM1 CT , STIM1 233-498 and STIM1 233-463 indicated α-helical contents of 49%, 54% and 57%, respectively ( Supplementary Fig. 4) . The α-helical contents and the [θ] 222 /[θ] 208 ratios, ~1, of the latter fragments provide strong experimental support for the predicted coiled coil.
Recombinant STIM1 binds to ORAI1
We used a membrane-flotation assay to evaluate binding of these recombinant STIM1 proteins to ORAI1. For these experiments, we expressed ORAI1 , an N-terminally truncated ORAI1 protein that forms functional Ca 2+ channels in mammalian cells (Supplementary Fig. 5 ), in the yeast Pichia pastoris. We prepared microsomal membranes from P. pastoris expressing ORAI1 65-301 , layered these membranes at the bottom of a discontinuous sucrose gradient and centrifuged them. After centrifugation, the recombinant ORAI1 was recovered near the top of the gradient in the fraction visually identified as containing membranes (Fig. 2a) , as expected for an integral membrane protein. STIM1 CT centrifuged together with control membranes from yeast not expressing ORAI1 remained at the bottom of the gradient, as expected for a soluble protein. However, when we mixed STIM1 CT with membranes containing ORAI1 and then centrifuged them, a substantial fraction of STIM1 CT rose with the membranes into the upper part of the gradient, demonstrating its interaction with ORAI1. STIM1 and all the longer STIM1 fragments tested in this assay also clearly bound ORAI1, whereas STIM1 233-463 did not bind detectably.
Recruitment of ORAI1 to puncta by full-length STIM1 depends on a direct or indirect interaction of STIM1 with the C-terminal cytoplasmic tail of ORAI1 (refs. 26,46) . Therefore, we next examined the direct interaction of recombinant STIM1 proteins with a bacterially expressed fusion protein, GST-ORAI1 CT , containing the cytoplasmic tail of ORAI1, residues 259-301. STIM1 CT and the other STIM1 fragments, except for STIM1 233-463 , bound to GST-ORAI1 CT immobilized on resin (Fig. 2b) . Binding was dependent on recognition of ORAI1 CT , as there was no binding to GST alone. Because we visualized all input and bound proteins on the gel with Coomassie Brilliant Blue staining and detected no other proteins, the current experiment provides unambiguous proof of a direct protein-protein interaction between STIM1 CT and ORAI1 CT .
A conserved region of ORAI1 immediately preceding, and extending into, ORAI1 transmembrane segment 1 is implicated in channel Figure 3 STIM1 triggers ORAI1-dependent Ca 2+ efflux from membrane vesicles of S. cerevisiae. (a) Above, principle of the Ca 2+ flux assay using Fura-2. Initially, the external Ca 2+ concentration is low and the peak of the free Fura-2 excitation spectrum is ~365 nm. When STIM1 gates the ORAI1 channel, Ca 2+ is released from the vesicles, Fura-2 binds Ca 2+ and the excitation peak is shifted to ~340 nm. Middle, Fura-2 excitation spectra of control and ORAI1-containing vesicles, with no addition or after the addition of ionomycin (20 µM) or STIM1 cytoplasmic fragments (2 µM). Below, graph of the fluorescence intensity ratio of Fura-2 (F 340nm /F 380nm ) in each condition. Error bars indicate the range of duplicate measurements. (b) Above, principle of the Ca 2+ flux assay using the FRET-based Ca 2+ sensor cameleon D4cpV. In unstimulated vesicles, internal Ca 2+ concentration is sufficient for binding to a fraction of the sensor, and cyan fluorescent protein−yellow fluorescent protein (CFP-YFP) FRET is evident in the peak at ~528 nm. When STIM1 gates the ORAI1 channel, Ca 2+ is released from the vesicles, Ca 2+ dissociates from the sensor, and there is a decline in the YFP peak at ~528 nm accompanied by an increase in the CFP peak at ~475 nm. Middle, D4cpV fluorescence emission spectra of control and ORAI1-containing vesicles, with no addition or after the addition of ionomycin (20 µM) or STIM1 cytoplasmic fragments (2 µM). Below, graph of the fluorescence intensity ratio of D4cpV (F 528nm /F 475nm ) in each condition. Error bars indicate the range of duplicate measurements. a r t i c l e s (Fig. 2c) . This experiment required a large amount of input protein, and the fraction of input STIM1 retained by immobilized GST-ORAI1 peptide was small, indicating that the interaction is weaker than the STIM1 CT -ORAI1 CT interaction.
STIM1-ORAI1 interaction is sufficient for gating
We next asked whether STIM1-ORAI1 protein-protein interactions are sufficient to open the ORAI1 Ca 2+ channel. We obtained vesicles from sec6-4 S. cerevisiae expressing ORAI1 and incubated them under conditions in which Fura-2 was the principal Ca 2+ buffer in the extravesicular solution, to monitor Ca 2+ efflux 49 . Treatment with the Ca 2+ ionophore ionomycin increased the prominence of the peak of the Fura-2 excitation spectrum near 340 nm (Ca 2+ -dye complex) relative to the peak near 365 nm (free dye), indicating release of Ca 2+ to the extravesicular solution (Fig. 3a) . Addition of STIM1 CT or STIM1 233-498 also elicited efflux of Ca 2+ from vesicles with ORAI1, whereas addition of STIM1 233-463 had little effect (Fig. 3a) . The effects of STIM1 CT and STIM1 233-498 required ORAI1, because neither STIM1 fragment was effective in releasing Ca 2+ from control vesicles lacking ORAI1 (Fig. 3a) .
In complementary measurements, we monitored vesicular Ca 2+ directly by coexpressing ORAI1 with the Ca 2+ sensor D3cpV or D4cpV (ref. 50) fused to the α-mating-factor secretion signal to target the sensor to the vesicles. We isolated vesicles that had incorporated ORAI1 from sec6-4 yeast incubated at the restrictive temperature, and we diluted the vesicles into assay buffer. The intravesicular sensor gave a stable FRET signal at ~528 nm due to the internal Ca 2+ , indicating that the vesicles were not allowing Ca 2+ to leak out. Treatment with ionomycin reduced the FRET signal at ~528 nm and increased the donor signal at ~475 nm, corresponding to depletion of vesicular Ca 2+ (Fig. 3b) . Addition of either STIM1 CT or STIM1 233-498 similarly triggered substantial loss of vesicular Ca 2+ (Fig. 3b) . For control vesicles lacking ORAI1, only ionomycin was effective in releasing Ca 2+ (Fig. 3b) .
We sought confirmation that Ca 2+ release from the vesicles was due to gating of the ORAI1 channel. Two mutant ORAI1 proteins that do not support Ca 2+ influx in mammalian cells-ORAI1 R91W, which cannot be activated by STIM1 (ref. 11), and ORAI1 E106Q, which is disabled in the ion-conducting pore 15 -were expressed individually in the sec6-4 strain for control experiments. Although each mutant ORAI1 protein was present in isolated vesicles at levels comparable to those of wild-type ORAI1 (Fig. 1b) , STIM1 CT did not elicit Ca 2+ release from vesicles containing either mutant protein (Fig. 4) . We conclude that the in vitro assay reflects STIM1-dependent gating of ORAI1 and Ca 2+ flux through the ORAI1 channel pore.
DISCUSSION
We have taken advantage of the absence of STIM-ORAI signaling in the yeast S. cerevisiae to show that recombinant STIM1 gates ORAI1 directly, without assistance from other proteins that have a dedicated role in the mammalian store-operated Ca 2+ entry pathway. It seems certain from RNAi studies that additional proteins in mammalian cells can modulate Ca 2+ influx through ORAI1 channels, but these proteins are not essential to channel function.
Our work implies that native STIM1 in cells interacts directly with ORAI1 across the ~17-nm distance 19 that separates the ER and plasma membrane. The store-operated channels formed by ORAI1 65-301 (Supplementary Fig. 5 ) and ORAI1 74-301 (ref. 46 ) have short cytoplasmic portions that cannot span this distance. Rather, as we have shown here, STIM1 forms a coiled coil of sufficient length to position the central region of the STIM1 cytoplasmic domain near the cytoplasmic face of the plasma membrane. The latter finding complements evidence that the region of STIM1 encompassing residues 344-442 causes constitutive activation of ORAI1 channels when expressed in mammalian cells 47, [51] [52] [53] .
Major questions remain about how specific STIM1-ORAI1 interactions participate in the gating conformational change, and about the conformational change itself. Our development of in vitro functional assays, with defined protein reagents, to probe the STIM1-ORAI1 interaction and Ca 2+ flux through the ORAI1 channel is an essential step toward the rigorous biochemical characterization of STIM1-ORAI1 gating.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
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ONLINE METhODS
Recombinant protein expression and characterization. We engineered STIM1, ORAI1, D3cpV and D4cpV expression constructs as described in Supplementary Methods 50, 54, 55 . We expressed recombinant STIM1 fragments in Escherichia coli, purified them and characterized them using CD spectroscopy and size exclusion chromatography coupled with SEC-MALLS. Binding of STIM1 fragments to recombinant ORAI1 cytoplasmic fragments was assessed in a pull-down assay using GST-tagged ORAI1 peptides. Experimental details are provided in Supplementary Methods 56 .
Pichia membrane-flotation assay. We assessed binding of STIM1 fragments to ORAI1 channels in their normal bilayer environment in a flotation assay, using microsomal membranes prepared from P. pastoris expressing human ORAI1 with an N-terminal Flag tag and the substitutions E106Q and N223A. We resuspended the microsomal membranes in 10 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT and 10% (v/v) glycerol, briefly sonicated the mixture, added EDTA from a concentrated stock to a final EDTA concentration of 25 mM, layered the suspension over a 0.5 M sucrose cushion and centrifuged at 149,000g for 1 h at 4 °C in a Beckman airfuge. The pelleted membranes were resuspended in the same buffer without EDTA and stored at −80 °C. For sucrose gradient membrane flotation, we mixed 30 µl of resuspended membrane and 10 µl of 5-10 µM purified STIM1 fragment with 400 µl of 73% (w/v) sucrose and loaded the mixture into the bottom of a 2-ml centrifuge tube. After incubation on ice for 30 min, the mixture at the bottom was overlaid with 1.2 ml of 60% (w/v) sucrose and further overlaid with 400 µl of 10% (w/v) sucrose. The solution was centrifuged at 100,000g for 16 h at 4 °C in a SW60 Ti rotor (Beckman Coulter). Five 400-µl fractions were collected from the top to bottom. We subjected a 40-µl aliquot of each fraction to electrophoresis in a 4-12% bis-Tris NuPAGE gel (Invitrogen) and western blotting. We detected Flag-tagged ORAI1 using anti-Flag M2 monoclonal antibody (Sigma), and we detected His 6 -tagged STIM1 fragments using anti−His tag monoclonal antibody (27E8 clone, Cell Signaling Technology).
Preparation of sec6-4 secretory vesicles. We used S. cerevisiae strain NY17 (obtained from R. Rao, Johns Hopkins University School of Medicine) featuring the temperature-sensitive sec6-4 mutation for protein expression and purification of secretory vesicles 38, 57 . We grew cells to midlog phase at 25 °C in uracildeficient synthetic complete medium containing glucose, which was subsequently exchanged for galactose to induce transgene expression over a period of 8 h. We then switched the temperature to 37 °C for 3 h to force intracellular accumulation of secretory vesicles. We collected cells by centrifugation at 4,000g for 5 min at 4 °C, washed them once in ice-cold water, resuspended them at a concentration of 50-60 OD 600 (optical density at 600 nm) units per ml in 10 mM DTT, 100 mM Tris, pH 9.4, and shook them gently at room temperature (~25 °C) for 10 min. We then pelleted and resuspended the cells at 50-60 OD 600 units per ml in spheroplast buffer (1.4 M sorbitol, 50 mM K 2 HPO 4 , pH 7.5, 10 mM NaN 3 , 40 mM β-mercaptoethanol) containing Zymolyase 20T (50 units per gram of yeast wet weight) and incubated them for up to 1 h at 37 °C. We harvested spheroplasts at 3,000g for 5 min at 4 °C, resuspended them in spheroplast buffer containing 10 mM MgCl 2 and 1 mg ml −1 concanavalin A at a density corresponding to 50 OD 600 units per ml of the starting culture and gently shook them at 4 °C for 15 min. We pelleted lectin-coated spheroplasts in a Sorvall H6000A rotor at 3,000g for 5 min at 4 °C, and resuspended them at 60-70 OD 600 units per ml in storage buffer (0.8 M sorbitol, 10 mM triethanolamine acetate, pH 7.2, containing complete protease inhibitor cocktail EDTA-free (Roche)) and homogenized at 4 °C in a Dounce homogenizer with 30 strokes of the pestle. We pelleted unlysed cells, cell debris, mitochondria and nuclei by centrifugation at 20,000g for 10 min at 4 °C in an SW 55 Ti rotor. We pelleted vesicles in the supernatant by centrifugation at 144,000g for 1 h at 4 °C in an SW 55 Ti rotor, resuspended them in storage buffer and stored them at 4 °C. We detected Myc-tagged ORAI1 in western blots using the mouse anti-Myc monoclonal antibody 9E10.
Fluorescence-based Ca 2+ flux assays using sec6-4 secretory vesicles. We used freshly prepared STIM1 in all experiments. For measurements with Fura-2, we pretreated all reagents and buffers, including ionomycin, Fura-2 pentasodium salt (Invitrogen) and purified STIM1 CT fragments, with Calcium Sponge S resin (Invitrogen) to remove traces of Ca 2+ . We verified the effectiveness of this treatment by examining Fura-2 spectra of the working solutions. To load Ca 2+ into the secretory vesicles, we incubated sec6-4 vesicles with 5 mM CaCl 2 in storage buffer, briefly sonicated and centrifuged them at 100,000g for 15 min at 4 °C in a Beckman airfuge. We gently resuspended the pelleted vesicles in 20 mM Tris, pH 7.4, and 100 mM KCl and passed them through Calcium Sponge S resin in a Micro-spin column (~30-µm pore size; Pierce) to reduce extravesicular residual metal ions to low nanomolar levels 49 .
We recorded Fura-2 spectra at ambient temperature, 22-25 °C, in 20 mM Tris, pH 7.4, and100 mM KCl containing 10 µM metal-free Fura-2. We recorded excitation spectra by scanning from 300-450 nm while monitoring emission at 510 nm, using a 2-nm to 4-nm slit width for both excitation and emission. Where indicated, we added purified STIM1 CT fragment to the cuvette to a final concentration of 2-3 µM, or we added ionomycin to a final concentration of 20 µM.
We monitored changes in intravesicular Ca 2+ concentration with the modified Ca 2+ sensors cameleon D3cpV and D4cpV (ref. 50). We made measurements at ambient temperature in 20 mM Tris, pH 7.4, and 100 mM KCl. We recorded emission spectra from 450-560 nm with excitation set at 410 nm, with a 5-nm to 8-nm slit width for both excitation and emission, and corrected the spectra by subtracting the spectrum obtained with buffer alone. A step intended to load the vesicles with Ca 2+ , as described above, seemed to cause only a modest increase in intravesicular Ca 2+ concentration but improved the signal in the case of D4cpV. This step had little effect on the signal from D3cpV. The appropriate STIM1 concentration is to some extent dependent on the concentration of vesicles. For the experiments shown, we used STIM1 CT and STIM1 fragments at a final concentration of 2-3 µM and vesicles at a protein concentration of 25-75 µg ml −1 .
Assays in mammalian cells. We expressed STIM1 fragments transiently in STIM1 −/− T cells and expressed ORAI1 65-301 in siRNA-treated HEK 293 cells to assay their ability to reconstitute store-operated Ca 2+ entry. We expressed ORAI1-YFP and mCherry-STIM1 fragments transiently in HEK 293 cells to examine their localization by confocal fluorescence microscopy. Details are given in Supplementary Methods 11, 58, 59 .
